Literature DB >> 15130222

Leptin in morbidly obese patients: no role for treatment of morbid obesity but important in the postoperative immune response.

Jeroen Nijhuis1, Francois M H Van Dielen, Wim A Buurman, Jan Willem M Greve.   

Abstract

Despite the current opinion that leptin can no longer be seen as a hormone which could be used therapeutically to prevent an energy surplus (it rather protects the organism for an energy deficit), leptin may still have an impact in clinical medicine. Leptin was shown to have several important functions. The pleiotropic properties of leptin include a regulatory function in the immune system. Reviewing the effects of leptin on different parts of the immune system reveals that the immune system is deregulated in an environment low in leptin. A strong reduction in leptin levels occurs in situations of starvation as seen after bariatric surgery. We postulate the hypothesis that the starvation-induced postoperative decrease of leptin is causative of the more serious course of complications observed after bariatric surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15130222     DOI: 10.1381/096089204323013451

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  3 in total

Review 1.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

2.  Nutrigenomic analysis of diet-gene interactions on functional supplements for weight management.

Authors:  Francis C Lau; Manashi Bagchi; Chandan Sen; Sashwati Roy; Debasis Bagchi
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

3.  Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease) after laparoscopic Roux-en-Y gastric bypass for morbid obesity: a case report.

Authors:  Juan Garcia-Arnes; M Rosa Bernal-Lopez; Jose Luis Gallego-Perales; M Luz Vazquez-Camuñas; Ricardo Gomez-Huelgas
Journal:  J Med Case Rep       Date:  2012-10-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.